Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB09078 | Lenvatinib | 0 | Recruiting | 1 |
DB09037 | Pembrolizumab | 0 | Recruiting | 1 |
DB11740 | Adavosertib | 1 | Active Not Recruiting | 1 |
DB00958 | Carboplatin | 1 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
DB01248 | Docetaxel | 1 | Active Not Recruiting | 1 |
DB00544 | Fluorouracil | 1 | Active Not Recruiting | 1 |
DB00526 | Oxaliplatin | 1 | Active Not Recruiting | 1 |
DB01229 | Paclitaxel | 1 | Recruiting | 1 |
DB09037 | Pembrolizumab | 1 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
DB00020 | Sargramostim | 1 | Recruiting | 1 |
DB18672 | Suratadenoturev | 1 | Recruiting | 1 |
DB08937 | TAS-102 | 1 | Recruiting | 1 |
DB11760 | Talazoparib | 1 | Recruiting | 1 |
DB04485 | Thymidine | 1 | Recruiting | 1 |
DB09343 | Tipiracil | 1 | Recruiting | 1 |
DB00432 | Trifluridine | 1 | Recruiting | 1 |
DB06599 | Lexatumumab | 2 | Recruiting | 1 |
DB01229 | Paclitaxel | 2 | Recruiting | 1 |
DB05578 | Ramucirumab | 2 | Recruiting | 1 |
DB08937 | TAS-102 | 2 | Recruiting | 1 |
DB09343 | Tipiracil | 2 | Recruiting | 1 |
DB00432 | Trifluridine | 2 | Recruiting | 1 |
DB00543 | Amoxapine | 3 | Recruiting | 1 |
DB00958 | Carboplatin | 3 | Recruiting | 1 |
DB01248 | Docetaxel | 3 | Recruiting | 1 |
DB00544 | Fluorouracil | 3 | Recruiting | 1 |
DB01229 | Paclitaxel | 3 | Recruiting | 1 |